BioSpace News Archive

Dr. Pardoll is a world-renowned cancer researcher in the field of immuno-oncology.

The company announced that Indivior has reported that the FDA has accepted the NDA for RBP-7000.

PQ Bypass, today announced it has received conditional approval of its investigational device exemption (IDE) from the FDA to initiate the pivotal DETOUR II clinical trial.

The Offering will be undertaken on a best efforts basis pursuant to the terms and conditions of an agency agreement to be entered into between the Company and the Canadian agent as the Company’s sole agent for the Offering in Canada.

Leica Biosystems and KUB Technologies are pleased to announce a new global distribution agreement for Kubtec’s specimen imaging systems.

Xenco Medical announces the release of TraumaGPS, the first on-demand trauma surgery delivery app with real-time GPS driver tracking for its disposable implant systems.

The results utilizing the SweDCIS randomized trial confirmed that DCISionRT-The DCIS Test-predicts which patients with DCIS will benefit from radiation therapy after breast conserving surgery.

In his new position, Fiordaliso will oversee managerial reporting and budgeting, financial planning and analysis, revenue forecasting and recognition, collaboration finance and expense management for Astellas Americas.

TriNetX’s NLP service utilizes sophisticated algorithms to extract clinical facts from physician notes and clinical reports, links them with other Electronic Medical Record data, and makes the combined data available for assessing study feasibility, protocol design, site selection, and subsequent identification of patients for clinical trials.

Nephros received the tax credit certificates through the New Jersey Technology Business Tax Certificate Transfer Program.